In accordance with previous research, data analysis from this research revealed a significantly higher serum concentration of IL-17A in the serum of women with early breast cancer at diagnosis, but also after surgical removal of the tumor during adjuvant treatment compared to the control group. Here, IL17A is linked to neoplasm.